Funding Positions Company for Commercial Launch of XenFi

为XenFi的商业发布提供资金支持

™

商标

, Continued Innovation of Wireless Medical Devices and Technologies and its AI-Enabled Physical Intelligence

无线医疗设备与技术的持续创新及其人工智能赋能的物理智能

™

商标

Platform

平台

Expands Board of Directors with Appointment of Financial Executive Linda Vega

任命财务高管琳达·维加，扩充董事会成员

DRAPER, Utah

犹他州德拉珀

,

，

July 16, 2026

2026年7月16日

/PRNewswire/ --

/美通社/ --

Xenter, Inc.

Xenter 公司

, the world's first TechMed™ company that has developed a healthcare intelligence platform for diagnostic evaluation and wireless medical devices that captures Physical Intelligence™ (PI) data over the XenFi™ wireless ecosystem, today announced the successful close on June 30

，全球首家TechMed™公司，该公司开发了一个用于诊断评估的医疗智能平台以及通过XenFi™无线生态系统捕获物理智能™（PI）数据的无线医疗设备，今日宣布于6月30日成功完成融资关闭。

th

泰国

of its Series B financing, raising a total of $58.25 million.

其B轮融资，共筹集资金5825万美元。

Continue Reading

继续阅读

Xenter also announced the appointment of Linda Vega to its Board of Directors. Linda brings decades of executive leadership in banking, finance, corporate governance, and strategic capital planning.

Xenter 还宣布任命琳达·维加（Linda Vega）为其董事会成员。琳达在银行业、金融业、公司治理及战略资本规划领域拥有数十年的高层领导经验。

The financing attracted participation from existing shareholders, prominent family offices, and healthcare investors who share the Xenter vision of transforming the way healthcare data is captured, connected, and utilized in hospitals and physicians' offices. The proceeds will support commercial launch, continued development of Xenter's proprietary technologies, manufacturing expansion, clinical and regulatory initiatives, and the acceleration of the company's integrated TechMed platform..

本轮融资吸引了现有股东、知名家族办公室以及医疗健康领域投资者的参与，这些投资者均认同 Xenter 关于变革医院和医生办公室中医疗数据的采集、连接与使用方式的愿景。所募资金将用于支持商业化发布、持续开发 Xenter 的专有技术、扩大生产规模、推进临床与监管事务，并加速公司集成式 TechMed 平台的发展。

'The closing of Series B strongly validates Xenter's wireless Physical Intelligence platform and enables the first commercial launch of our diagnostics business unit and the initiation of planned clinical testing of the Guru™ dual sensor physiology guidewire in Transcatheter Aortic Valve Replacement (TAVR) procedures,' said Richard J.

“B轮融资的完成有力验证了Xenter的无线物理智能平台，并推动了我们的诊断业务部门首次实现商业化发布，同时启动了Guru™双传感器生理导丝在经导管主动脉瓣置换术（TAVR）中的计划性临床试验。”Richard J.表示。

Linder, Founder, Chairman and Chief Executive Officer of Xenter. 'This financing represents more than capital, it reflects the confidence our investors have in our long-term vision to fundamentally change how healthcare technologies communicate, generate data, and improve patient outcomes.'.

林德，Xenter 创始人、董事长兼首席执行官。“此次融资不仅意味着资金注入，更体现了投资者对我们长期愿景的信心——即从根本上改变医疗技术之间的通信方式、数据生成方式，并改善患者预后。”

Richard J. Linder continued, 'Healthcare has historically been built around disconnected devices and computers on wheels with fragmented information systems. Xenter is building an integrated intelligence platform designed to connect medical devices, diagnostics, digital health, and AI into a seamless ecosystem that enables better clinical decision-making while continually ensuring patients control their healthcare data.'.

理查德·J·林德继续说道：“长期以来，医疗体系建立在彼此孤立的设备和移动电脑推车之上，信息系统支离破碎。Xenter 正在构建一个集成智能平台，旨在将医疗设备、诊断技术、数字健康和人工智能连接成一个无缝的生态系统，在确保持续由患者掌控其医疗数据的同时，助力更优的临床决策。”

Xenter also announced the appointment of Linda Vega to its Board of Directors. Linda brings decades of executive leadership in banking, finance, corporate governance, and strategic capital planning. A former executive with Wachovia Bank, Linda has advised organizations ranging from emerging growth companies to multinational enterprises on financial strategy, capital formation, governance, and long-term value creation..

Xenter 还宣布任命琳达·维加（Linda Vega）为其董事会成员。琳达在银行业、金融业、公司治理及战略资本规划方面拥有数十年的高层领导经验。作为前 Wachovia 银行的高管，她曾为从新兴成长型公司到跨国企业的各类组织提供财务战略、资本筹集、治理以及长期价值创造方面的咨询建议。

'It's a great honor to be appointed to Xenter's Board of Directors, a board that consists of some of the most experienced and legendary leaders in life sciences and medicine. I hope to bring my experience in business, finance and accounting to an already world-class board of directors,' said Linda Vega, Xenter's newest board member..

“很荣幸被任命为Xenter公司董事会成员，该董事会由生命科学和医学领域一些最具经验和传奇色彩的领导者组成。我希望将我在商业、金融和会计方面的经验带入这个已经世界一流的董事会。” Xenter最新董事会成员Linda Vega表示。

'Linda's experience guiding organizations through periods of significant growth and capital deployment will provide tremendous value as Xenter continues its next phase of expansion,' said Mr. Linder. 'Her financial expertise and strategic perspective will strengthen our Board as we continue executing our long-term vision.'.

“琳达在指导组织度过显著增长和资本部署阶段方面的经验，将在Xenter继续其下一阶段的扩张过程中提供巨大的价值。”林德先生说。“她的财务专长和战略视角将加强我们的董事会，因为我们将继续执行我们的长期愿景。”

About Xenter

关于 Xenter

Xenter is a privately held TechMed company defining a new category at the intersection of medical devices, data infrastructure, and clinical AI, turning real-time high-fidelity data into a scalable intelligence layer for healthcare. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is introducing novel technology solutions that connect clinical data across the continuum of care..

Xenter 是一家私营的 TechMed 公司，正在医疗设备、数据基础设施和临床人工智能的交叉领域定义一个全新类别，将实时高保真数据转化为可扩展的医疗智能层。Xenter 由经验丰富的生命科学企业家 Richard J. Linder 于 2020 年创立，旨在推出创新的技术解决方案，连接贯穿整个护理 continuum 的临床数据。

The Xenter Physical Intelligence platform grows with every procedure, continuously expanding its library of clinical, procedural, and diagnostic data to drive future innovation and empower patients, providers, and health systems to make the right decisions. Headquartered in Draper, Utah, Xenter is advancing the development of intelligent, connected healthcare technologies.

Xenter 物理智能平台随着每一次医疗操作不断成长，持续扩充其临床、操作和诊断数据库，以推动未来创新，并赋能患者、医疗服务提供者及医疗系统做出正确决策。Xenter 总部位于犹他州德拉珀，致力于推进智能化、互联化医疗技术的发展。

Learn more at .

了解更多，请访问。

www.xenter.io

www.xenter.io

.

。

SOURCE Xenter, Inc.

来源 Xenter 公司

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

请求演示